Back
Disc Medicine Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
77
IRON
Disc Medicine
Last Price:
50.00
Seasonality Move:
1.34%
Sell
25
ALNY
Alnylam Pharmaceuticals
Last Price:
267.99
Seasonality Move:
4.48%
Buy
77
Disc Medicine (IRON)
is a Buy
Is Disc Medicine a Buy, Sell or Hold?
- The current Disc Medicine [IRON] share price is $50.15. The Score for IRON is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- IRON is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $269.55. The Score for ALNY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IRON Stock Price Chart
What is Disc Medicine's stock price today?
-
The Disc Medicine share price today is $50.15
The current trend is moderately bullish and IRON is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $269.55
The current trend is moderately bearish and ALNY is experiencing slight selling pressure.
IRON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 54.95 | Buy |
| Chaikin Money Flow: | -76541 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.62 - 50.58) | Buy |
| Bollinger Bands (100): | (38.37 - 49.73) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.88 | Buy |
| Relative Strength Index (14 RSI): | 50.99 | Buy |
| Chaikin Money Flow: | -223814 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (257.29 - 276.95) | Buy |
| Bollinger Bands (100): | (179.69 - 279.19) | Buy |
IRON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.54 | Buy |
| 20-day SMA: | 48.94 | Buy |
| 50-day SMA: | 47.44 | Buy |
| 200-day SMA: | 48.89 | Buy |
| 8-day EMA: | 49.91 | Buy |
| 20-day EMA: | 49.13 | Buy |
| 50-day EMA: | 47.67 | Buy |
| 200-day EMA: | 46.24 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 273.16 | Sell |
| 20-day SMA: | 268.51 | Buy |
| 50-day SMA: | 265.44 | Buy |
| 200-day SMA: | 196.5 | Buy |
| 8-day EMA: | 272.44 | Sell |
| 20-day EMA: | 270.39 | Sell |
| 50-day EMA: | 259.97 | Buy |
| 200-day EMA: | 214.22 | Buy |
Disc Medicine Earnings Growth & IRON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.28 per share, and a decrease next year of $0.51 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.
Disc Medicine Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||